Gastric cancer
Conditions
Interventions
Experimental Group:During the preoperative waiting period after hospital admission, study participants received a leucine-restricted diet for three days prior to surgery. Surgical intervention was per
Sponsors
Qilu Hospital of Shandong University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Pathologically confirmed gastric carcinoma requiring preoperative endoscopic localization marking or delineation of the lesion extent. 2.Aged between 18 and 70 years, regardless of gender. 3.Ability to consume oral or nasogastric tube feeding of a liquid diet. 4.Provision of signed informed consent and voluntary participation in this study. 5.No evidence of distant metastasis on preoperative imaging studies (e.g., CT, PET-CT), and deemed suitable for surgical resection. 6.No concurrent diagnosis of other active malignancies.
Exclusion criteria
Exclusion criteria: 1.Presence of cognitive impairment or psychological disorders that may compromise the understanding of the research content. 2.Diagnosis of Type I or Type II Diabetes Mellitus. 3.Severe diarrhea, intractable vomiting, severe malabsorption syndromes, paralytic or mechanical intestinal obstruction, or active gastrointestinal bleeding. 4.Known allergy to the primary components of the leucine-deficient nutritional formula. 5.Concurrent use of other nutritional supplements that may interfere with the trial's efficacy. 6.Postoperative pathological diagnosis confirming non-primary gastric cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amino acid concentration; | — |
Secondary
| Measure | Time frame |
|---|---|
| CD8+ T cell percentage; | — |
Countries
China
Contacts
Public ContactHui Qu
Qilu Hospital of Shandong University
Outcome results
None listed